©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessCerebellar hypoplasia, expanded differential diagnosis

Summary

Short information

Comprehensive differential diagnostic panel for Cerebellar hypoplasia comprising 17 core candidate genes and altogether 63 curated genes according to the clinical signs

ID
KP9124
Number of genes
64 Accredited laboratory test
Examined sequence length
35,6 kb (Core-/Core-canditate-Genes)
178,7 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Material
  • EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications

NGS +

 

Gene panel

Selected genes

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
AMPD22478NM_001368809.2AR
CASK2766NM_003688.3XL
CHMP1A591NM_002768.5AR
CLP11086NM_001142597.2AR
EXOSC3828NM_016042.4AR
OPHN12409NM_002547.3XLR
RARS21737NM_020320.5AR
RELN10383NM_005045.4AR
SEPSECS1506NM_016955.4AR
TSEN21398NM_025265.4AR
TSEN34933NM_024075.5AR
TSEN541581NM_207346.3AR
TUBA1A1356NM_006009.4AD
TUBB2B1338NM_178012.5AD
TUBB31353NM_006086.4AD
VLDLR2622NM_003383.5AR
VRK11191NM_003384.3AR
ADGRG12064NM_005682.7AR
ATAD3A1761NM_001170535.3AR
ATP8A23567NM_016529.6AR
B3GALNT21503NM_152490.5AR
B4GAT11248NM_006876.3AR
CA8873NM_004056.6AR
CACNA1G6945NM_018896.5AD
CDK5783NM_001164410.3AR
COASY1695NM_025233.7AR
COL3A14401NM_000090.4AD, AR
CRPPA1356NM_001101426.4AR
CWF19L11617NM_018294.6AR
DAG12688NM_004393.6n.k.
DCC4344NM_005215.4AR
DDX3X1986NM_001193416.3XL
DKC11545NM_001363.5XLR
EXOSC8831NM_181503.3AR
FKRP1488NM_024301.5AR
FKTN1386NM_001079802.2AR
GMPPB1164NM_013334.4AR
HEATR5B6251
  • No OMIM-Gs linked
NM_019024.3AR
ITPR18088NM_002222.7AD, AR
KCNC32274NM_004977.3AD
LARGE12271NM_004737.7AR
MACF116293NM_012090.5AD
PCLO14808NM_014510.3AR
PHGDH1602NM_006623.4AR
POMGNT11983NM_017739.4AR
POMGNT21743NM_032806.6AR
POMT12244NM_007171.4AR
POMT22253NM_013382.7AR
PTF1A987NM_178161.3AR
ROBO34161NM_022370.4AR
RXYLT11355NM_014254.3AR
SLC25A461257NM_138773.4AR
SNAP29777NM_004782.4AR
SNX142841NM_153816.6AR
SPTBN27173NM_006946.4AD, AR
SRD5A3957NM_024592.5AR
TBC1D232100NM_001199198.3AR
TERT3399NM_198253.3AR
TINF21356NM_001099274.3AD
TOE11488NM_025077.4AR
TSEN15390NM_001127394.4AR
VPS35L3462NM_020314.7AR
VPS532499NM_001128159.3AR
WDR815826NM_001163809.2AR

Informations about the disease

Clinical Comment

Group of heterogenous disorders

 

Synonyms
  • Alias: Zerebellare Hypoplasie
  • Allelic: Axenfeld-Rieger syndrome, type 3 (FOXC1)
  • Allelic: COACH syndrome 2 (CC2D2A)
  • Allelic: Cardiomyopathy, dilated, 1X (FKTN)
  • Allelic: Colorectal cancer, somatic (DCC)
  • Allelic: Congenital heart defects, nonsyndromic, 1, XL (ZIC3)
  • Allelic: Dyskeratosis congenita, AD 2 (TERT)
  • Allelic: Dyskeratosis congenita, AD 3 (TINF2)
  • Allelic: Ehlers-Danlos syndrome, vascular type (COL3A1)
  • Allelic: Epilepsy, familial temporal lobe, 7 (RELN)
  • Allelic: Esophageal carcinoma, somatic (DCC)
  • Allelic: FG syndrome 4 (CASK)
  • Allelic: Fibrosis of extraocular muscles, congenital, 3A (TUBB3)
  • Allelic: Gastrointestinal defects + immunodeficiency syndrome 2 (PI4KA)
  • Allelic: Heterotaxy, visceral, 1, X (ZIC3)
  • Allelic: Hypertriglyceridaemia [panelapp] (CELSR2)
  • Allelic: Intellectual disability [MONDO:0001071] (HEATR5B)
  • Allelic: Leukemia, acute myeloid (TERT)
  • Allelic: Melanoma, cutaneous malignant, 9 (TERT)
  • Allelic: Mental retardation, with/-out nystagmus (CASK)
  • Allelic: Muscular dystrophy-dystroglycanopathy (cong. +/- mental retardation), type B, 5(FKRP)
  • Allelic: Muscular dystrophy-dystroglycanopathy [cong. with mental retardation], type B, 1 (POMT1)
  • Allelic: Muscular dystrophy-dystroglycanopathy [cong. with mental retardation], type B, 14 (GMPPB)
  • Allelic: Muscular dystrophy-dystroglycanopathy [cong. with mental retardation], type B, 2 (POMT2)
  • Allelic: Muscular dystrophy-dystroglycanopathy [cong. with mental retardation], type B, 3 (POMGNT1)
  • Allelic: Muscular dystrophy-dystroglycanopathy [cong. with mental retardation], type B, 6 (LARGE1)
  • Allelic: Muscular dystrophy-dystroglycanopathy [cong. without mental retardation], type B, 4 (FKTN)
  • Allelic: Muscular dystrophy-dystroglycanopathy [limb-girdle], type C, 1 (POMT1)
  • Allelic: Muscular dystrophy-dystroglycanopathy [limb-girdle], type C, 14 (GMPPB)
  • Allelic: Muscular dystrophy-dystroglycanopathy [limb-girdle], type C, 2 (POMT2)
  • Allelic: Muscular dystrophy-dystroglycanopathy [limb-girdle], type C, 3 (POMGNT1)
  • Allelic: Muscular dystrophy-dystroglycanopathy [limb-girdle], type C, 4 (FKTN)
  • Allelic: Muscular dystrophy-dystroglycanopathy [limb-girdle], type C, 5 (FKRP)
  • Allelic: Muscular dystrophy-dystroglycanopathy [limb-girdle], type C, 7 (CRPPA)
  • Allelic: Muscular dystrophy-dystroglycanopathy [limb-girdle], type C, 8 (POMGNT2)
  • Allelic: Muscular dystrophy-dystroglycanopathy [limb-girdle], type C, 9 [DAG1]
  • Allelic: Neuropathy, hereditary motor + sensory, type VIB (SLC25A46)
  • Allelic: Osteogenesis imperfecta, type XV (WNT1)
  • Allelic: Pancreatic agenesis 2 (PTF1A)
  • Allelic: Polymicrogyria, bilateral perisylvian (ADGRG1)
  • Allelic: Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1 (TERT)
  • Allelic: Retinitis pigmentosa 76 (POMGNT1)
  • Allelic: Retinitis pigmentosa 93 (CC2D2A)
  • Allelic: Short-rib thoracic dysplasia 4 +/- polydactyly (TTC21B)
  • Allelic: Thyroid carcinoma, follicular (MINPP1)
  • Alkuraya-Kucinskas syndrome (BLTP1)
  • Allelic: VACTERL association, XL (ZIC3)
  • Bardet-Biedl syndrome 13 (MKS1)
  • Bardet-Biedl syndrome 20 (IFT172)
  • CEBALID syndrome (MN1)
  • COACH syndrome 1 (TMEM67)
  • Cerebellar ataxia + mental retardation with/-out quadrupedal locomotion 3 (CA8)
  • Cerebellar ataxia, mental retardation + dysequilibrium syndrome 2 (WDR81)
  • Cerebellar ataxia, mental retardation + dysequilibrium syndrome 4 (ATP8A2)
  • Cerebellar dysfunction, impaired intellectual development, hypogonadotropic hypogonadism (PRDM13)
  • Cerebellar hypoplasia + mental retardation with/-out quadrupedal locomotion 1 (VLDLR)
  • Cerebellofaciodental syndrome (BRF1)
  • Cerebral dysgenesis, neuropathy, ichthyosis + palmoplantar keratoderma syndrome (SNAP29)
  • Chudley-McCullough syndrome (GPSM2)
  • Congenital disorder of glycosylation, type Ia (PMM2)
  • Congenital disorder of glycosylation, type Iq (SRD5A3)
  • Cortical dysplasia, complex, with other brain malformations 1 (TUBB3)
  • Cortical dysplasia, complex, with other brain malformations 7 (TUBB2B)
  • Cortical dysplasia, complex, with other brain malformations 9 (CTNNA2)
  • Dandy Walker Syndrome [panelapp] (FOXC1)
  • Developmental + epileptic encephalopathy 66 (PACS2)
  • Dyskeratosis congenita, AR 4 (AR)
  • Dyskeratosis congenita, XL (DKC1)
  • Fanconi anemia, complementation group B (FANCB)
  • Gaze palsy, familial horizontal, with progressive scoliosis, 1 (ROBO3)
  • Gaze palsy, familial horizontal, with progressive scoliosis, 2 (DCC)
  • Gillespie syndrome (ITPR1)
  • Harel-Yoon syndrome (ATAD3A)
  • Holoprosencephaly 5 (ZIC2)
  • Hydrocephalus, congenital, 3, with brain anomalies (WDR81)
  • Hydrocephalus, focal epilepsy + hemiparesis [panelapp] (NID1)
  • Hypogonadotropic hypogonadism 20 with or without anosmia (FGF17)
  • Intellectual developmental disorder, X-linked syndromic, Snijders Blok type (DDX3X)
  • Jeune syndrome (TTC21B)
  • Joubert syndrome 1 (INPP5E)
  • Joubert syndrome 10 (OFD1)
  • Joubert syndrome 12 (KIF7)
  • Joubert syndrome 13 (TCTN1)
  • Joubert syndrome 14 (TMEM237)
  • Joubert syndrome 15 (CEP41)
  • Joubert syndrome 16 (TMEM138)
  • Joubert syndrome 17 (CPLANE1)
  • Joubert syndrome 18 (TCTN3)
  • Joubert syndrome 19 (ZNF423)
  • Joubert syndrome 2 (TMEM216)
  • Joubert syndrome 20 (TMEM231)
  • Joubert syndrome 21 (CSPP1)
  • Joubert syndrome 23 (KIAA0586)
  • Joubert syndrome 24 (TCTN2)
  • Joubert syndrome 25 (CEP104)
  • Joubert syndrome 26 (KATNIP)
  • Joubert syndrome 27 (B9D1)
  • Joubert syndrome 28 (MKS1)
  • Joubert syndrome 29 (TMEM107)
  • Joubert syndrome 3 (AHI1)
  • Joubert syndrome 30 (ARMC9)
  • Joubert syndrome 32 (SUFU)
  • Joubert syndrome 34 (B9D2)
  • Joubert syndrome 38 (KIAA0753)
  • Joubert syndrome 5 (CEP290)
  • Joubert syndrome 6 (TMEM67)
  • Joubert syndrome 7 (RPGRIP1L)
  • Joubert syndrome 8 (ARL13B)
  • Joubert syndrome 9 (CC2D2A)
  • Kahrizi syndrome (SRD5A3)
  • Leukodystrophy, hypomyelinating, 9 (RARS1)
  • Lissencephaly 2 [Norman-Roberts type] (RELN)
  • Lissencephaly 3 (TUBA1A)
  • Lissencephaly 8 (TMTC3)
  • Lissencephaly 9 with complex brainstem malformation (MACF1)
  • Macrothrombocytopenia, isolated, 2, AD (TUBA8)
  • Meckel syndrome 11 (TMEM231)
  • Meckel syndrome 13 (TMEM107)
  • Meckel syndrome 2 (TMEM216)
  • Meckel syndrome 3 (TMEM67)
  • Meckel syndrome 6 (CC2D2A)
  • Mega-corpus-callosum syndrome with cerebellar hypoplasia + cortical malformations (MAST1)
  • Mental retardation + microcephaly with pontine + cerebellar hypoplasia (CASK)
  • Mental retardation, XL, with cerebellar hypoplasia + distinctive facial appearance (OPHN1)
  • Mental retardation, truncal obesity, retinal dystrophy + micropenis (INPP5E)
  • Mirror movements 1 and/or agenesis of the corpus callosum (DCC)
  • Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10 (RXYLT1)
  • Muscular dystrophy-dystroglycanopathy [cong. with brain + eye anomalies], type A, 1 (POMT1)
  • Muscular dystrophy-dystroglycanopathy [cong. with brain + eye anomalies], type A, 11 (B3GALNT2)
  • Muscular dystrophy-dystroglycanopathy [cong. with brain + eye anomalies], type A, 13 (B4GAT1)
  • Muscular dystrophy-dystroglycanopathy [cong. with brain + eye anomalies], type A, 14 )GMPPB)
  • Muscular dystrophy-dystroglycanopathy [cong. with brain + eye anomalies], type A, 2 (POMT2)
  • Muscular dystrophy-dystroglycanopathy [cong. with brain + eye anomalies], type A, 3 (POMGNT1)
  • Muscular dystrophy-dystroglycanopathy [cong. with brain + eye anomalies], type A, 4 (FKTN)
  • Muscular dystrophy-dystroglycanopathy [cong. with brain + eye anomalies], type A, 5 (FKRP)
  • Muscular dystrophy-dystroglycanopathy [cong. with brain + eye anomalies], type A, 6 (LARGE1)
  • Muscular dystrophy-dystroglycanopathy [cong. with brain + eye anomalies], type A, 7 (CRPPA)
  • Muscular dystrophy-dystroglycanopathy [cong. with brain + eye anomalies], type A, 8 POMGNT2)
  • Muscular dystrophy-dystroglycanopathy [cong. with brain + eye anomalies], type A, 9 (DAG1)
  • Neu-Laxova syndrome 1 (PHGDH)
  • Neurodegeneration with brain iron accumulation 6 (COASY)
  • Neurodevelopmental disorder with microcephaly, arthrogryposis + structural brain anomalies (SMPD4)
  • Neurodevelopmental disorder with microcephaly, arthrogryposis, structural brain anomalies (SMPD4)
  • Orofaciodigital syndrome I (OFD1)
  • Orofaciodigital syndrome IV (TCTN3)
  • Orofaciodigital syndrome VI (CPLANE1)
  • Orofaciodigital syndrome XIV (C2CD3)
  • Orofaciodigital syndrome XVI (TMEM107)
  • Pancreatic + cerebellar agenesis (PTF1A)
  • Phosphoglycerate dehydrogenase deficiency (PHGDH)
  • Polymicrogyria +/- vascular-type EDS (COL3A1)
  • Polymicrogyria with optic nerve hypoplasia (TUBA8)
  • Polymicrogyria, bilateral frontoparietal (ADGRG1)
  • Polymicrogyria, perisylvian, with cerebellar hypoplasia + arthrogryposis (PI4KA)
  • Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis (PI4KA)
  • Pontocerebellar hypoplasia [MONDO:0020135] (HEATR5B)
  • Pontocerebellar hypoplasia type 10 (CLP1)
  • Pontocerebellar hypoplasia type 11 (TBC1D23)
  • Pontocerebellar hypoplasia type 12 (COASY)
  • Pontocerebellar hypoplasia type 16 (MINPP1)
  • Pontocerebellar hypoplasia type 17 (PRDM13)
  • Pontocerebellar hypoplasia type 1A (VRK1)
  • Pontocerebellar hypoplasia type 1B (EXOSC3)
  • Pontocerebellar hypoplasia type 1C (EXOSC8)
  • Pontocerebellar hypoplasia type 1E (SLC25A46)
  • Pontocerebellar hypoplasia type 2A (TSEN54)
  • Pontocerebellar hypoplasia type 2B (TSEN2)
  • Pontocerebellar hypoplasia type 2C (TSEN34)
  • Pontocerebellar hypoplasia type 2D (SEPSECS)
  • Pontocerebellar hypoplasia type 2E (VPS53)
  • Pontocerebellar hypoplasia type 2F (TSEN15)
  • Pontocerebellar hypoplasia type 3 (PCLO)
  • Pontocerebellar hypoplasia type 4 (TSEN54)
  • Pontocerebellar hypoplasia type 5 (TSEN54)
  • Pontocerebellar hypoplasia type 6 (RARS2)
  • Pontocerebellar hypoplasia type 7 (TOE1)
  • Pontocerebellar hypoplasia type 8 (CHMP1A)
  • Pontocerebellar hypoplasia, hypotonia + respiratory insufficiency syndrome, neonatal lethal (ATAD3A)
  • Poretti-Boltshauser syndrome (LAMA1)
  • Revesz syndrome (TINF2)
  • Ritscher-Schinzel syndrome 3 (C16orf62)
  • Simpson-Golabi-Behmel syndrome, type 2 (OFD1)
  • Spastic paraplegia 63 (AMPD2)
  • Spastic paraplegia 84, AR (PI4KA)
  • Spinocerebellar ataxia 13 (KCNC3)
  • Spinocerebellar ataxia 15 (ITPR1)
  • Spinocerebellar ataxia 29, congenital nonprogressive (ITPR1)
  • Spinocerebellar ataxia 42 (CACNA1G)
  • Spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits (CACNA1G)
  • Spinocerebellar ataxia 5 (SPTBN2)
  • Spinocerebellar ataxia, AR 14 (SPTBN2)
  • Spinocerebellar ataxia, AR 17 (CWF19L1)
  • Spinocerebellar ataxia, AR 20 (SNX14)
  • Structural brain anomalies with impaired intellectual development + craniosynostosis (ZIC1)
Heredity, heredity patterns etc.
  • AD
  • AR
  • XL
  • XLR
  • n.k.
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

No text defined